Codex DNA
Codex DNA's Overview
Codex DNA, Inc. (which later rebranded to Telesis Bio) was a synthetic biology company focused on developing and commercializing automated solutions for DNA and RNA synthesis. Their flagship product, the BioXp™ system, enabled researchers to rapidly and accurately build synthetic genes, genomes, and mRNA. The company aimed to empower scientists in fields like drug discovery, vaccine development, and personalized medicine by democratizing access to synthetic DNA. In 2022, Codex DNA rebranded to Telesis Bio. In June 2023, Telesis Bio filed for Chapter 11 bankruptcy, and its key assets were acquired by Integrated DNA Technologies (IDT) in August 2023.
Where is Codex DNA's Headquarters?
HQ Function
Served as the main center for research and development, manufacturing of its BioXp™ systems and reagents, corporate operations, marketing, sales, and customer support for its synthetic biology solutions.
Notable Features:
The facility likely included advanced laboratories for synthetic biology research, specialized manufacturing areas for instruments and reagents, and modern office spaces. Specific architectural highlights are not widely publicized but were designed to support a dynamic biotech R&D and production environment.
Work Culture:
As an innovator in synthetic biology, the work culture at Codex DNA likely emphasized scientific excellence, rapid innovation, collaboration, and a results-driven approach to tackling complex biological challenges. It would have been a fast-paced environment common in disruptive technology companies.
HQ Significance:
The San Diego headquarters was pivotal as the operational core for developing and commercializing the BioXp™ platform, significantly contributing to the automation of synthetic biology. It represented the company's commitment to advancing life sciences research within a prominent biotech ecosystem.
Values Reflected in HQ: The headquarters embodied values of innovation, precision, automation, and scientific advancement, focused on empowering researchers with cutting-edge tools for synthetic biology.
Location:
While its primary operations and headquarters were in San Diego, Codex DNA (later Telesis Bio) served a global customer base. Its international reach was facilitated through direct sales teams in key markets, a network of distributors in various regions, and field application scientists who provided on-site support, installation, and training for the BioXp™ systems worldwide.
Street Address:
9535 Waples Street, Suite 100
City:
San Diego
State/Province:
CA
Country:
USA
Codex DNA's Global Presence
Buying Intent Signals for Codex DNA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Codex DNA
As of April 2025, Codex DNA' leadership includes:
Investors of Codex DNA
Codex DNA has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the 12 months prior to May 2024, Telesis Bio (formerly Codex DNA) underwent Chapter 11 bankruptcy (June 2023) and subsequent asset acquisition by IDT (August 2023). This period saw the departure of its executive team as the original company ceased independent operations.
Departures
Technology (Tech Stack) used by Codex DNA
Discover the tools Codex DNA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Codex DNA Email Formats and Examples
Common email formats for companies like Codex DNA often involved combinations of first name, last name, or first initial with the last name. The domain used would have been @codexdna.com. These formats are now historical due to the company's acquisition.
flast@codexdna.com (e.g., first initial + last name)
Format
jdoe@codexdna.com
Example
75%
Success rate
News and media
GlobeNewswire • May 3, 2022
Codex DNA Rebrands as Telesis Bio
Codex DNA, Inc. announced its corporate name change to Telesis Bio, Inc., aiming to better reflect its expanding mission beyond DNA synthesis to empower scientists across biologics discovery, development, and biomanufacturing with its automated solutions....more
Endpoints News • June 16, 2023
Telesis Bio (formerly Codex DNA) files for Chapter 11 bankruptcy
Telesis Bio, the company previously known as Codex DNA, filed for Chapter 11 bankruptcy protection. The company stated its intention to pursue a sale of its assets, including its BioXp automated DNA and mRNA synthesis platform....more
Integrated DNA Technologies (IDT) • August 2, 2023
IDT Completes Acquisition of Key Telesis Bio (formerly Codex DNA) Assets
Integrated DNA Technologies (IDT) announced it had finalized the acquisition of key assets from Telesis Bio, Inc. This includes the BioXp™ automated synthesis platform, related intellectual property, and other associated assets, following Telesis Bio's bankruptcy proceedings....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Codex DNA, are just a search away.